Literature DB >> 22466814

The incidence of venous thromboembolism following stroke and its risk factors in eastern China.

Xingyang Yi1, Jing Lin, Zhao Han, Xudong Zhou, Xiaotong Wang, Jiguang Lin.   

Abstract

Few studies have documented the prevalence of venous thromboembolism (VTE) in the Chinese population. We aimed to investigate the incidence of VTE following stroke and to determine the potential risk factors for the onset of VTE in patients of eastern China. A prospective multi-center study was conducted. A total of 1,380 patients with acute stroke received venous duplex ultrasound (VDU) examination on both lower limbs. The National Institutes of Health Stroke Scale (NIHSS), Barthel index (BI), Wells, and modified Rankin scale scores were determined. Among 1,380 cases of acute stroke, 4.49 % (62 cases) had deep venous thrombosis (DVT) and 0.80 % (11 cases) had pulmonary thromboembolism (PTE). In the cases of DVT, 48.4 % had no clinical symptoms. The independent risk factors for the incidence of DVT, following the acute stage of stroke, were an age ≥ 70 years, bed-ridden, a Wells score ≥ 2, an NIHSS score of lower limbs ≥ 3, a low BI score, and an elevated concentration of D: -dimer. Rehabilitative and anti-coagulant therapy prevented the incidence of DVT following stroke. Moreover, an age ≥ 70 years, bed-ridden and having DVT were the independent risk factors for the incidence of PTE among stroke patients during the acute stage. Finally, 1.51 % of the patients had DVT whereas no PTE occurred during the period of the follow-up study. VDU examination is recommended for patients with acute stroke, which may help to diagnose and treat asymptomatic DVT early as well as prevent the subsequent incidence of PTE.

Entities:  

Mesh:

Year:  2012        PMID: 22466814     DOI: 10.1007/s11239-012-0720-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  24 in total

1.  Revisiting the past strengthens the present: an evidence-based medicine approach for the diagnosis of deep venous thrombosis.

Authors:  Russell D Hull
Journal:  Ann Intern Med       Date:  2005-04-05       Impact factor: 25.391

2.  The value of a risk factor analysis in clinically suspected deep venous thrombosis.

Authors:  E Oger; C Leroyer; E Le Moigne; M P Pomey; L Bressollette; J Clavier; D Mottier
Journal:  Respiration       Date:  1997       Impact factor: 3.580

Review 3.  Venous thromboembolism in stroke: literature review and implications for clinical practice.

Authors:  M E Brandstater; E J Roth; H C Siebens
Journal:  Arch Phys Med Rehabil       Date:  1992-05       Impact factor: 3.966

4.  Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.

Authors:  P M Bath; E Lindenstrom; G Boysen; P De Deyn; P Friis; D Leys; R Marttila; J Olsson; D O'Neill; J Orgogozo; B Ringelstein; J van der Sande; A G Turpie
Journal:  Lancet       Date:  2001-09-01       Impact factor: 79.321

5.  [Study on the risk factors of deep venous thrombosis in acute hospitalized stroke patients].

Authors:  Kui-Kui Sun; Chen Wang; Bao-Sen Pang; Yuan-Hua Yang; Wen He; Tian-Feng Chen; Qi-Huang Zhao; Jian Zhang
Journal:  Zhonghua Liu Xing Bing Xue Za Zhi       Date:  2004-12

Review 6.  Venous thromboembolism after acute stroke.

Authors:  J Kelly; A Rudd; R Lewis; B J Hunt
Journal:  Stroke       Date:  2001-01       Impact factor: 7.914

7.  Venous thromboembolism after acute ischemic stroke: a prospective study using magnetic resonance direct thrombus imaging.

Authors:  J Kelly; A Rudd; R R Lewis; C Coshall; A Moody; B J Hunt
Journal:  Stroke       Date:  2004-08-19       Impact factor: 7.914

Review 8.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.

Authors:  David G Sherman; Gregory W Albers; Christopher Bladin; Cesare Fieschi; Alberto A Gabbai; Carlos S Kase; William O'Riordan; Graham F Pineo
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321

10.  Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke.

Authors:  S T McCarthy; J Turner
Journal:  Age Ageing       Date:  1986-03       Impact factor: 10.668

View more
  10 in total

1.  Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis.

Authors:  Andrea J Darzi; Samer G Karam; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Mary Cushman; Michael K Gould; Lawrence Mbuagbaw; Frederick A Spencer; Alex C Spyropoulos; Michael B Streiff; Scott Woller; Neil A Zakai; Federico Germini; Marta Rigoni; Arnav Agarwal; Rami Z Morsi; Alfonso Iorio; Elie A Akl; Holger J Schünemann
Journal:  Blood       Date:  2020-05-14       Impact factor: 22.113

2.  Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment.

Authors:  Andrea J Darzi; Samer G Karam; Frederick A Spencer; Alex C Spyropoulos; Lawrence Mbuagbaw; Scott C Woller; Neil A Zakai; Michael B Streiff; Michael K Gould; Mary Cushman; Rana Charide; Itziar Etxeandia-Ikobaltzeta; Federico Germini; Marta Rigoni; Arnav Agarwal; Rami Z Morsi; Elie A Akl; Alfonso Iorio; Holger J Schünemann
Journal:  Blood Adv       Date:  2020-06-23

3.  Low-molecular-weight heparin or dual antiplatelet therapy is more effective than aspirin alone in preventing early neurological deterioration and improving the 6-month outcome in ischemic stroke patients.

Authors:  Xingyang Yi; Wanzhang Chi; Chun Wang; Biao Zhang; Jing Lin
Journal:  J Clin Neurol       Date:  2015-01-02       Impact factor: 3.077

4.  Risk Factors for DVT/PE in Patients with Stroke and Intracranial Hemorrhage.

Authors:  Mark Stecker; Kathleen Michel; Karin Antaky; Sarah Cherian; Feliks Koyfmann
Journal:  Open Neurol J       Date:  2014-04-04

5.  Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.

Authors:  Ludvig B Rinde; Birgit Småbrekke; Ellisiv B Mathiesen; Maja-Lisa Løchen; Inger Njølstad; Erin M Hald; Tom Wilsgaard; Sigrid K Brækkan; John-Bjarne Hansen
Journal:  J Am Heart Assoc       Date:  2016-11-07       Impact factor: 5.501

6.  Prediction of deep vein thrombosis by ultrasonography and D-dimer in Asian patients with ischemic stroke.

Authors:  Sang Hee Ha; Yeon-Jung Kim; Sung Hyuk Heo; Dae-Il Chang; Bum Joon Kim
Journal:  BMC Neurol       Date:  2020-06-27       Impact factor: 2.474

7.  Establishment of a risk assessment tool for pregnancy-associated venous thromboembolism and its clinical application: protocol for a prospective observational study in Beijing.

Authors:  Yi Chen; Yan Dai; Jing Song; Ling Wei; Ying Ma; Ning Tian; Qian Wang; Qian Zhang; Yue Zhang; Xiao Lan Wang; Jun Zhang; Rong Liu
Journal:  BMC Pregnancy Childbirth       Date:  2019-08-13       Impact factor: 3.007

8.  The Role of Vitamin D in the Relationship Between Gender and Deep Vein Thrombosis Among Stroke Patients.

Authors:  Jiejie Tao; Feiling Lou; Yuntao Liu
Journal:  Front Nutr       Date:  2021-12-02

9.  Development and Validation of a Risk Assessment Model for Venous Thromboembolism in Patients With Invasive Mechanical Ventilation.

Authors:  Jiajia Lin; Yue Zhang; Weixian Lin; Ying Meng
Journal:  Cureus       Date:  2022-07-23

Review 10.  D-Dimer elevation and adverse outcomes.

Authors:  Rim Halaby; Christopher J Popma; Ander Cohen; Gerald Chi; Marcelo Rodrigues Zacarkim; Gonzalo Romero; Samuel Z Goldhaber; Russell Hull; Adrian Hernandez; Robert Mentz; Robert Harrington; Gregory Lip; Frank Peacock; James Welker; Ignacio Martin-Loeches; Yazan Daaboul; Serge Korjian; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2015-01       Impact factor: 2.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.